| |JULY 2026191,000 budding intensivists actively participates in questioning, discussing, and building the clinical competencies that modern ICU practice demands. He also remembers to thank Dr D. Malthi Raja and his family for the success behind every milestone. The company also operates an Anytime Service (ATS), a 24x7 emergency medicine supply commitment that mobilises field representatives at any hour to deliver critical medicines to hospitals across every tier, ensuring no patient waits because of a supply failure. India Book of Records. 11 Newspapers. One Mission.Two years in, Aionios Pharma's record of public advocacy is as notable as its commercial one.On World Sepsis Day 2025, the company collaborated with the General Post Office, Bengaluru, to launch a Special Postal Cover, unveiled by Padma Shri Dr C.N. Manjunath- spotlighting five critical facts and five life-saving actions around sepsis. Supported by the Department of Posts, Karnataka Circle, and leading medical experts, the initiative was covered across 11 regional and national newspapers, including nine Kannada, one Tamil, one Telugu, and one English publication.Earlier, Aionios Pharma united critical care specialists from across India in a nationwide signature movement on T-shirts: a campaign that earned the company a place in the Asia and India Book of Records for its scale and symbolism. From Bangalore to every corner of India, signatures on T-shirts became more thanink; they became a visible, recorded commitment to sepsis awareness.Beyond healthcare, the company's Minds of Change CSR initiative identifies academically meritorious students from economically disadvantaged backgrounds and fully funds their medical education, a direct, long-term investment in the next generation of Indian doctors.The Road AheadCommercially, the company's roadmap is clear. By 2028, Aionios Pharma targets revenues of Rs 108 crore. Export formulations are already in planning, and company has received queries for the exports which would be commenced at the earliest."We are not in a hurry to grow fast. We are focused on growing right. Aionios should be known for trust, consistency, and clinical relevance, and when we build that, our legacy in this industry will be assured", concludes N. K. Raja.From 1,000 hospitals today to a 2,500+ crore enterprise by 2045, Aionios Pharma is not just building a business. It is building the infrastructure for better patient outcomes across India, one deliberate step at a time. PO
< Page 9 | Page 11 >